Allied Minds teams up with Boston University to develop cardiac tech

US science and technology developer Allied Minds is to form a new subsidiary, Signature Medical, to work with Boston University to develop a wearable device to monitor heart failure.

Signature Medical has secured a worldwide option to license patent rights from the university for its cardiac technology.

It plans to develop technology that was researched in the university's electrical and computer engineering department for a wearable device which could allow healthcare providers to diagnose and monitor patients with heart failure when they have been discharged from hospital, as well as for use in hospital therapy.

London-listed Allied Minds claims that heart failure is the number one cause of hospitalisation for adults over the age of 65 in the US and consumes between 1-2% of healthcare expenditures in developed countries.

The company’s goal for the monitoring system is to improve outcomes for patients while saving costs, in part, by minimising re-admissions.

Omar Amirana, chief executive of Signature Medical and senior vice president of, Allied Minds, said: "Today's heart failure treatments could be significantly improved through the use of wearable devices to improve diagnostics and monitoring to reduce hospitalisations and readmissions."